A Triple Top wants to break out. The stock was trading down around 5 bucks a share and then Blammo. It went up. And yes, Blammo is the name of the company’s new anti-constipation drug.
A huge hit.
So it went up up up to here at 15 bucks tripled in value in just a few months. But then sober reality began to hit the investing community. There simply wasn’t enough constipation to go around. So the stock began to flag and traded down to here at 12 bucks.
But then Blammo again released big news: A partnership with Manischewitz brand Matzo and the American Cheese Manufacturing Association. So the stock raced again to 15. But no.....there just wasn’t enough enthusiasm from buyers to pay more than 15 bucks a share for it, despite this newly kind of created market.
So the stock sank back to 12, only to then have investment interest from Procter & Gamble, owners of Charmin who bought 5 percent of the company at 13.50. And left a lot of investors thinking that they’d buy the whole company, complete with its product line of anti-constipation drinks, Whammo Blammo, Thank ya, Ma’am-o.
But alas, the investment community would not pay up past 15 a share and the stock flagged again, sinking back to 12, having created a triple top and needing something to make things really start, you know...going….
So yeah, that’s a triple top. What about a triple bottom? Well a triple bottom is basically just the same thing in reverse. Keeps hitting a low point, looking like it’s going to bottom out further...but then recovers.
On the subject of bottoming out… Blammo is now available in new, chewable gummy form. Blammo—so you never have to worry when your bottom’s...um…out.